Literature DB >> 9934750

Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.

J Genesca1, A Gonzalez, R Segura, R Catalan, R Marti, E Varela, G Cadelina, M Martinez, J C Lopez-Talavera, R Esteban, R J Groszmann, J Guardia.   

Abstract

OBJECTIVE: Nitric oxide has been proposed as a mediator of hyperdynamic circulation in cirrhosis. Endotoxin and cytokines induce the synthesis of nitric oxide. The aim of this study was to investigate the relationship between endotoxemia, cytokines, and nitric oxide in patients with cirrhosis, and to correlate these findings with clinical, biochemical, and hemodynamic parameters.
METHODS: Clinical, biochemical, and hemodynamic parameters were assessed in 66 patients with cirrhosis and 15 controls. Levels of antidiuretic hormone, plasma renin activity, aldosterone, interferon gamma, interleukin-1, interleukin-6, tumor necrosis factor alpha, endotoxin, and nitrates-nitrites were determined.
RESULTS: Mean arterial pressure was lower and interleukin-6, tumor necrosis factor alpha, nitrites-nitrates levels, and endotoxin positivity rates were higher in cirrhotics than in controls (p < 0.005). Mean arterial pressure decreased and interleukin-6 levels increased with worsening of Child score (p < 0.005). Patients with ascites had higher levels of interleukin-6, tumor necrosis factor alpha, and nitrates-nitrites than patients without ascites (p < 0.01). Elevated levels of interleukin-6 were found in patients with encephalopathy grade I, compared with patients without (p < 0.001); this association was independent of the severity of liver disease. In patients with low mean arterial pressure, interleukin-6 levels were higher than in patients with high mean arterial pressure (p = 0.001), whereas tumor necrosis factor alpha and nitrates-nitrites levels were not different. By multivariate analysis, high interleukin-6 levels showed independent associations with the presence of ascites, encephalopathy, and low mean arterial pressure. Only interleukin-6 levels had significant correlations with Child score, plasma renin activity, serum and urinary sodium, and mean arterial pressure (r > or = 0.4, p < 0.005).
CONCLUSIONS: Although the activity of the nitric oxide pathway is increased in patients with cirrhosis and might contribute to the hemodynamic alteration, other factors are involved. Interleukin-6, possibly through nitric oxide-independent mechanisms, also might play a role in the vasodilatation of cirrhosis and the pathogenesis of hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9934750     DOI: 10.1111/j.1572-0241.1999.00790.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  23 in total

1.  Physiopathology of splanchnic vasodilation in portal hypertension.

Authors:  María Martell; Mar Coll; Nahia Ezkurdia; Imma Raurell; Joan Genescà
Journal:  World J Hepatol       Date:  2010-06-27

2.  Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.

Authors:  Georgios Kalambokis; Michalis Economou; Andreas Fotopoulos; Jihad Al Bokharhii; Pappas Christos; Kosta Paraskevi; Papadimitriou Konstantinos; Afroditi Katsaraki; Epameinondas V Tsianos
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

3.  Interleukin-6 and its soluble receptor in patients with liver cirrhosis and hepatocellular carcinoma.

Authors:  Maurizio Soresi; Lydia Giannitrapani; Fabio D'Antona; Ada-Maria Florena; Emanuele La Spada; Angela Terranova; Melchiorre Cervello; Natale D'Alessandro; Giuseppe Montalto
Journal:  World J Gastroenterol       Date:  2006-04-28       Impact factor: 5.742

4.  Tumor necrosis factor-alpha, interleukin-6, and nitric oxide in sterile ascitic fluid and serum from patients with cirrhosis who subsequently develop ascitic fluid infection.

Authors:  J Such; D J Hillebrand; C Guarner; L Berk; P Zapater; J Westengard; C Peralta; G Soriano; J Pappas; B A Runyon
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

5.  Severity of Systemic Inflammatory Response Syndrome Affects Outcomes in Decompensated Cirrhotics with Spontaneous Bacterial Peritonitis.

Authors:  Jennifer D Twilla; Satheesh P Nair; Manish Talwar; Alexander Kovalic; Sanjaya K Satapathy
Journal:  Am J Gastroenterol       Date:  2016-07       Impact factor: 10.864

6.  MELD score, insulin-like growth factor 1 and cytokines on bone density in end-stage liver disease.

Authors:  Rebecca Mitchell; Jill McDermid; Mang M Ma; Constance L Chik
Journal:  World J Hepatol       Date:  2011-06-27

7.  Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis.

Authors:  C Rodríguez-Ramos; F Galan; F Díaz; J Elvira; L Martín-Herrera; J A Girón-González
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

8.  Rifaximin Decreases the Incidence and Severity of Acute Kidney Injury and Hepatorenal Syndrome in Cirrhosis.

Authors:  Tien Dong; Andrew Aronsohn; K Gautham Reddy; Helen S Te
Journal:  Dig Dis Sci       Date:  2016-09-21       Impact factor: 3.199

9.  Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites.

Authors:  Soong Lee; Seung-Cheol Son; Moon-Jong Han; Woo-Jin Kim; Soo-Hyun Kim; Hye-Ran Kim; Woo-Kyu Jeon; Ki-Hong Park; Myung-Geun Shin
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

10.  Bedside sublingual video imaging of microcirculation in assessing bacterial infection in cirrhosis.

Authors:  Muhammad Y Sheikh; Usman Javed; Jasjit Singh; Jayanta Choudhury; Omer Deen; Kulraj Dhah; Michael W Peterson
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.